A novel schlemm's canal scaffold increases outflow facility in a human anterior segment perfusion model

Lucinda J. Camras, Fan Yuan, Shan Fan, Thomas W. Samuelson, Ike K. Ahmed, Andrew T. Schieber, Carol B Toris

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

PURPOSE. An intracanalicular scaffold (Hydrus microstent) designed to reduce intraocular pressure as a glaucoma treatment was tested in human anterior segments to determine changes in outflow facility (C). METHODS. Human eyes with no history of ocular disease or surgeries were perfused within 49 hours of death. The anterior segments were isolated and connected to a perfusion system. Flow rates were measured at pressures of 10, 20, 30, and 40 mm Hg. The scaffold was inserted into Schlemm's canal of the experimental eye, while a control eye underwent a sham procedure. Flow rate measurements were repeated at the four pressure levels. Individual C values were computed by dividing the flow rate by its corresponding pressure, and by averaging the four individual C measurements. The change in C between control and experimental eyes was assessed by the ratio of the baseline and second C measurement. In two eyes, the placement of the scaffold was evaluated histologically. RESULTS. After scaffold implantation in the experimental eyes, the average C increased significantly from baseline (n = 9, P < 0.05). Ratios of C at all pressure levels, except for 10 mm Hg, were significantly higher in experimental eyes (n = 9) than control eyes (P < 0.05, n = 7). Histologically, the scaffold dilated Schlemm's canal with no visible damage to the trabecular meshwork. CONCLUSIONS. The Hydrus Microstent provided an effective way to increase outflow facility in human eyes ex vivo.

Original languageEnglish (US)
Pages (from-to)6115-6121
Number of pages7
JournalInvestigative Ophthalmology and Visual Science
Volume53
Issue number10
DOIs
StatePublished - Sep 1 2012

Fingerprint

Perfusion
Pressure
Trabecular Meshwork
Eye Diseases
Intraocular Pressure
Glaucoma

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

A novel schlemm's canal scaffold increases outflow facility in a human anterior segment perfusion model. / Camras, Lucinda J.; Yuan, Fan; Fan, Shan; Samuelson, Thomas W.; Ahmed, Ike K.; Schieber, Andrew T.; Toris, Carol B.

In: Investigative Ophthalmology and Visual Science, Vol. 53, No. 10, 01.09.2012, p. 6115-6121.

Research output: Contribution to journalArticle

Camras, Lucinda J. ; Yuan, Fan ; Fan, Shan ; Samuelson, Thomas W. ; Ahmed, Ike K. ; Schieber, Andrew T. ; Toris, Carol B. / A novel schlemm's canal scaffold increases outflow facility in a human anterior segment perfusion model. In: Investigative Ophthalmology and Visual Science. 2012 ; Vol. 53, No. 10. pp. 6115-6121.
@article{b44085879bc340abb5929ac4e1f83758,
title = "A novel schlemm's canal scaffold increases outflow facility in a human anterior segment perfusion model",
abstract = "PURPOSE. An intracanalicular scaffold (Hydrus microstent) designed to reduce intraocular pressure as a glaucoma treatment was tested in human anterior segments to determine changes in outflow facility (C). METHODS. Human eyes with no history of ocular disease or surgeries were perfused within 49 hours of death. The anterior segments were isolated and connected to a perfusion system. Flow rates were measured at pressures of 10, 20, 30, and 40 mm Hg. The scaffold was inserted into Schlemm's canal of the experimental eye, while a control eye underwent a sham procedure. Flow rate measurements were repeated at the four pressure levels. Individual C values were computed by dividing the flow rate by its corresponding pressure, and by averaging the four individual C measurements. The change in C between control and experimental eyes was assessed by the ratio of the baseline and second C measurement. In two eyes, the placement of the scaffold was evaluated histologically. RESULTS. After scaffold implantation in the experimental eyes, the average C increased significantly from baseline (n = 9, P < 0.05). Ratios of C at all pressure levels, except for 10 mm Hg, were significantly higher in experimental eyes (n = 9) than control eyes (P < 0.05, n = 7). Histologically, the scaffold dilated Schlemm's canal with no visible damage to the trabecular meshwork. CONCLUSIONS. The Hydrus Microstent provided an effective way to increase outflow facility in human eyes ex vivo.",
author = "Camras, {Lucinda J.} and Fan Yuan and Shan Fan and Samuelson, {Thomas W.} and Ahmed, {Ike K.} and Schieber, {Andrew T.} and Toris, {Carol B}",
year = "2012",
month = "9",
day = "1",
doi = "10.1167/iovs.12-9570",
language = "English (US)",
volume = "53",
pages = "6115--6121",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "10",

}

TY - JOUR

T1 - A novel schlemm's canal scaffold increases outflow facility in a human anterior segment perfusion model

AU - Camras, Lucinda J.

AU - Yuan, Fan

AU - Fan, Shan

AU - Samuelson, Thomas W.

AU - Ahmed, Ike K.

AU - Schieber, Andrew T.

AU - Toris, Carol B

PY - 2012/9/1

Y1 - 2012/9/1

N2 - PURPOSE. An intracanalicular scaffold (Hydrus microstent) designed to reduce intraocular pressure as a glaucoma treatment was tested in human anterior segments to determine changes in outflow facility (C). METHODS. Human eyes with no history of ocular disease or surgeries were perfused within 49 hours of death. The anterior segments were isolated and connected to a perfusion system. Flow rates were measured at pressures of 10, 20, 30, and 40 mm Hg. The scaffold was inserted into Schlemm's canal of the experimental eye, while a control eye underwent a sham procedure. Flow rate measurements were repeated at the four pressure levels. Individual C values were computed by dividing the flow rate by its corresponding pressure, and by averaging the four individual C measurements. The change in C between control and experimental eyes was assessed by the ratio of the baseline and second C measurement. In two eyes, the placement of the scaffold was evaluated histologically. RESULTS. After scaffold implantation in the experimental eyes, the average C increased significantly from baseline (n = 9, P < 0.05). Ratios of C at all pressure levels, except for 10 mm Hg, were significantly higher in experimental eyes (n = 9) than control eyes (P < 0.05, n = 7). Histologically, the scaffold dilated Schlemm's canal with no visible damage to the trabecular meshwork. CONCLUSIONS. The Hydrus Microstent provided an effective way to increase outflow facility in human eyes ex vivo.

AB - PURPOSE. An intracanalicular scaffold (Hydrus microstent) designed to reduce intraocular pressure as a glaucoma treatment was tested in human anterior segments to determine changes in outflow facility (C). METHODS. Human eyes with no history of ocular disease or surgeries were perfused within 49 hours of death. The anterior segments were isolated and connected to a perfusion system. Flow rates were measured at pressures of 10, 20, 30, and 40 mm Hg. The scaffold was inserted into Schlemm's canal of the experimental eye, while a control eye underwent a sham procedure. Flow rate measurements were repeated at the four pressure levels. Individual C values were computed by dividing the flow rate by its corresponding pressure, and by averaging the four individual C measurements. The change in C between control and experimental eyes was assessed by the ratio of the baseline and second C measurement. In two eyes, the placement of the scaffold was evaluated histologically. RESULTS. After scaffold implantation in the experimental eyes, the average C increased significantly from baseline (n = 9, P < 0.05). Ratios of C at all pressure levels, except for 10 mm Hg, were significantly higher in experimental eyes (n = 9) than control eyes (P < 0.05, n = 7). Histologically, the scaffold dilated Schlemm's canal with no visible damage to the trabecular meshwork. CONCLUSIONS. The Hydrus Microstent provided an effective way to increase outflow facility in human eyes ex vivo.

UR - http://www.scopus.com/inward/record.url?scp=84868643252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868643252&partnerID=8YFLogxK

U2 - 10.1167/iovs.12-9570

DO - 10.1167/iovs.12-9570

M3 - Article

C2 - 22893672

AN - SCOPUS:84868643252

VL - 53

SP - 6115

EP - 6121

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 10

ER -